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Edited by Judit OvadiAbstract Calcineurin (CN) is a heterodimer consisting of a
catalytic subunit (CNA) and a regulatory subunit (CNB). The
crystal structure shows that three residues or regions of CNA are
mainly responsible for the interaction with CNB: the CNB
binding helix (BBH), the N-terminus, and Glu53 that forms a
salt bridge with Lys134 of CNB. In this report, we try to ﬁnd the
role that the salt bridge plays in the interaction between CNA
and CNB. We found that mutation of Glu53 greatly reduced its
responsiveness to CNB in the phosphatase assay and also that
mutation of Lys134 of CNB aﬀected its ability to activate the
phosphatase activity of CNA. Structural analysis showed that
disruption of the salt bridge aﬀected the compact association of
CNA and CNB. Thus, the salt bridge appears to help to stabilize
CN and transfer the eﬀects of CNB binding to CNA to activate
its phosphatase activity.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Interaction1. Introduction
Calcineurin (CN) is a major calmodulin (CaM)-binding
protein in the brain and the only serine/threonine protein
phosphatase under the control of Ca2þ/calmodulin [1–3]. It
plays a critical role in coupling Ca2þ signals to cellular re-
sponses, and is involved in many signaling pathways, such as
T-cell activation, the cell cycle, apoptosis and survival of cer-
tain cells [4–6].
CN is a heterodimer composed of a catalytic subunit A
(CNA) and a regulatory subunit B (CNB) [7]. CNA contains
four functional domains: a catalytic domain, a CNB binding
domain (BBH), a CaM binding domain and an autoinhibitory
domain (AID) [8–10]. CNB is an ‘EF-hand’ Ca2þ binding
protein. The crystal structure of human CN-FKBP12-FK506
[11,12] shows that CNB has two globular domains ﬂanked by a
long C-terminal b-strand. The two domains are arranged lin-
early along the BBH and form a 33 A-long hydrophobic
groove with an amphipathic C-terminus. The top half of the
BBH is embedded in the groove. Additional contacts occur* Corresponding author. Fax: +86-010-622-07365.
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doi:10.1016/j.febslet.2004.10.002between the N-terminus of CNA and the C-terminal lobe of
CNB forming part of the binding cleft, and a salt bridge is
formed between Glu53 of CNA and Lys134 of CNB.
It is well known that without CNB, CNA has little activity
even in the presence of Ca2þ/CaM. However, the details of
how CNB interacts with and regulates CNA are not well de-
ﬁned. The interaction between BBH and the hydrophobic
groove of CNB is essential for the stability of CN and muta-
tions that alter the hydrophobic character of the two regions
often disrupt the association between CNA and CNB [13,14].
It is not known how the salt bridge and the N-terminus of
CNA inﬂuence the interaction between CNA and CNB and
the regulation by CNB of the phosphatase activity of CNA.
Here, we focus on the function of the salt bridge in the in-
teraction between CNA and CNB. We separately mutated the
Glu-53 of CNA to Glycine and Alanine, and the Lys134 of
CNB to Glycine, to disrupt the salt bridge, yielding three salt
bridge-disabled mutants: E53G, E53A, and K134G. Analysis
of the phosphatase activity and structure of these mutants
showed that the salt bridge is very important for CN function.2. Materials and methods
2.1. Plasmid construction
All mutations were obtained by PCR. E53G and E53A were con-
structed with the following primer pairs and full-length rat CNA
cDNA as template: E53G, sense 50-CTC ATG AAGGGAGGC AGG
CTG-30, antisense 50-CAG CCT GCC TCC CTT CAT GAG-30. E53A,
sense 50-CTC ATG AAG GCA GGC AGG CTG-30. antisense, 50-
CAG CCT GCC TGC CTT CAT GAG-30. The CNB mutant K134G
was constructed with full-length rat CNB cDNA as template and the
primer pairs were: sense 50 -CAG ATT GTA GAC GGA ACC ATA
ATA AAC GC-30, antisense 50–GCG TTT ATT ATG GTT CCG TCT
ACA ATC TG-30. The CNA genes were cloned into the pET21a ex-
pression vector using the NdeI and HindIII restriction sites, and the
corresponding primers were: sense 50-AGG AGA TAT ACA TAT
GTC CGA GCC CAA GGC-30 and antisense 50-CGC GAA GCT
TTC ACT GAA TAT TGC T-30. K134G was cloned into pET21a
using the NdeI and BamHI restriction sites, and the corresponding
primers were: sense 50-CCG CCA TAT GGG AAA TGA GGC GAG
TT-30 and antisense 50-CGC GGG ATC CTC ACA CAT CTA CCA
CCA-30.
2.2. Expression and puriﬁcation of proteins
The target proteins were expressed and puriﬁed as previously de-
scribed [15,16]. Protein concentrations were measured by the proce-
dure of Bradford [17] and protein purity was assessed by SDS–PAGE.
2.3. Assay of phosphatase activity
Phosphatase activity was assayed as described [18]. Brieﬂy, 10 ll of
20 nM enzyme solution was mixed with 10 ml assay buﬀer (40 mM 32P-blished by Elsevier B.V. All rights reserved.
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1 mM Mn2þ, and 0.2 mM CaCl2, pH7.4; with or without 0.6 mM
CaM) at 30 C for 10 min. CNB or K134G was added in a molar ratio
of 1:1 to CNA. The reaction was terminated with 0.18 ml of 83.3 mM
H3PO4, and the released
32P was separated from the RII peptide and
quantiﬁed by liquid scintillation spectrometry.2.4. CD spectroscopy
CD experiments were performed on a CD instrument (Jasco J-720,
Japan) calibrated with d10-camphorsulfonic acid. All spectra were re-
corded at 20 C with constant N2 ﬂushing using a bandwidth of 1.0 nm
in a cuvette of 1 mm path length. The enzyme concentration was 2.7
mM in 20 mM Tris–Cl, pH 7.4, 0.5 mM MnCl2 and 3 mM CaCl2.
CNB/K134G was added in a molar ratio of 1:1 to CNA and their
concentrations were set at 53 mM when their spectra were assayed
separately. The measurement was repeated twice and the data were
normalized to mean residue ellipticity (MRw). The percentage of sec-
ondary structures contents was estimated using the software in the CD
instruments [19,20].2.5. UV-absorbance spectroscopy
UV-absorbance spectroscopy was performed on a GBC UV-visible
Cintra 10e spectrometer at 25 C in a cuvette of 1 cm path length and
slit-width of 1.5 nm. Absorbance spectra were recorded from 240 to
320 nm with protein free buﬀer as the blank control. The enzyme
concentration was 8.2 mM in 20 mM Tris–Cl, pH 7.4, 0.5 mM MnCl2
and 3 mM CaCl2. CNB/K134G was added in a molar ratio of 1:1 to
CNA and their concentrations were set at 26 mM when their spectra
were assayed separately.3. Results
3.1. Expression and puriﬁcation of proteins
DNA sequence analysis conﬁrmed the mutant sequences
(date not shown). The proteins were puriﬁed as described in
Section 2. SDS–PAGE analysis showed that mutants E53G
and E53A had the same mobility as WT CNA as well as
mutant K134G migrated with similar mobility to CNB. All
proteins were electrophoretically pure (Fig. 1).Fig. 1. SDS–PAGE analysis of puriﬁed proteins. Lane 1, protein
markers; lane 2, CNA; lane 3, E53G; lane 4, E53A; lane 5, CNB; lane
6, K134G.3.2. Phosphatase activity
3.2.1. The eﬀect of CNB and K134G on the phosphatase
activity of CNA. The eﬀect of K134G on the phosphatase
activity of CNA was weaker than that of CNB. The activity
of CNA in the presence of K134G was only about 75% of
that observed in the presence of CNB whether CaM was
present or not (Fig. 2A).
3.2.2. The eﬀect of CNB on CNA and its derivatives. It is
out of our anticipation that mutation of the salt bridge of
CNA greatly reduced the sensitivity of CNA to CNB. The
presence of CNB increased the phosphatase activity of WT
CNA about 24-fold, whereas with E53G and E53A it increased
only 3.41- and 1.84-fold, respectively. When CaM and CNBFig. 2. Phosphatase activity was assayed as described in Section 2. (A)
The eﬀect of CNB and K134G on the phosphatase activity of CNA in
the presence and absence of CaM. (B) The eﬀect of CNB on the
phosphatase activity of CNA and its mutant derivatives in the presence
and absence of CaM. (C) The phosphatase activity of CNA and its
mutants in the presence and absence of CaM. The data with error bars
are expressed as meansS.D. (n ¼ 3).
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tants was still much lower than WT CNA (Fig. 2B).
3.2.3. The phosphatase activity of CNA and its derivatives
The basal phosphatase activities of CNA and its mutants did
not diﬀer greatly. The phosphatase activity of E53G and E53A
alone were 2.1 and 1.1 times that of WT CNA, respectively
(Fig. 2C). In addition, the eﬀect of CaM on the phosphatase
activity of the CNA derivatives was similar, indicating that the
substitutions at Glu53 did not inhibit CaM binding to CNA.Table 1
The percentage of secondary structures contents was estimated using the softw
in Figs. 3 and 4
a-Helix (%) b-Sheet (%) b-Turn (%) Random c
(A) The computed percentage of secondary structure contents of CNB/K134
CNB 28.3 39.2 2.7 29.8
K134G 29.1 37.8 3.3 29.8
CNA+CNB 23.0 27.9 22.4 26.7
CNA+K134G 22.8 32.1 18.2 26.9
a-Helix (%) b-Sheet (%)
CNB CNBþ CNB CNBþ
(B) The computed percentage of secondary structure contents of CNA and
CNA 21.3 23.0 34.5 27.9
E53G 33.0 20.9 21.5 41.1
E53A 30.3 20.6 33.1 38.5
A B
DC
Fig. 3. CD and UV spectra assay of CNB and K134G. (A) CD spectra
of CNB and K134G. (B) CD spectra of CNB and K134G in the
presence of CNA. (C) UV spectra of CNB and K134G. (D) UV spectra
of CNB and K134G in the presence of CNA.3.3. CD and UV-absorbance spectra
3.3.1. The CD and UV-absorbance spectra of CNB and
K134G. There are minor diﬀerences between both the CD
spectra and UV spectra of CNB and K134G whether CNA
present or not (Fig. 3). Table 1(A) indicates that the secondary
structures of CNB and K134G are a little diﬀerent. We pre-
sume that disruption of the salt bridge aﬀects the correct
conformation forming between CNA and CNB.
3.3.2. The CD and UV-absorbance spectra of CNA and its
derivatives. The CD spectra of E53G and E53A had somewhat
greater negative peaks than WT CNA (Fig. 4A), and their a-
helix contents are much higher than WT CNA (Table 1(B)).
The UV-absorbance spectra of WT CNA and E53A were
similar, but E53G had a higher peak at 265 nm (Fig. 4C).
3.3.3. The CD and UV-absorbance spectra of CNA and its
derivatives in the presence of CNB. In the presence of CNB, the
CD spectra of E53G and E53A were almost the same, with a
lower negative peak than WT CNA (Fig. 4B). When CNB
added, the changes in the UV spectra of the various forms of
CNA are quite similar when compared with the spectra in the
absence of CNB (Fig. 4D). The fact that changes in secondary
structures of CNA and its mutants are diﬀerent upon addition
of CNB (Table 1(B)) indicates that our mutation may aﬀect the
correct binding of CNB to CNA and the formation of correct
conformation.4. Discussion
The essential role of CNB in supporting CN phosphatase
activity and the requirement of CNB for Ca2þ has been well
established [21,22], but it is not clear how CNB interacts with
and regulates CNA. The crystal structure of human CN-
FKBP12-FK506 reveals that three regions of CNA are mainly
responsible for the interaction with CNB: the BBH, the N-
terminus and residue Glu53 that forms a salt bridge with
Lys134 of CNB [11,12]. The corresponding region of CNB is
the latch region, an element of the tertiary structure that forms
when CNB binds CNA and is considered important in both
docking of the immunosuppressant–immunophilin complex
and phosphatase activation [13]. The hydrophobic features of
BBH and CNB are important for complexing of CNA and
CNB [13,23]. Little is known about the role of the salt bridge in
the interaction of CNA and CNB.are in Jasco J-720 CD instruments according to the CD spectra showed
oil (%)
G, respectively and with CNA
b-Turn (%) Random coil (%)
CNB CNBþ CNB CNBþ
its derivatives in the absence and presence of CNB
19.6 22.4 24.6 26.8
12.9 13.2 32.6 24.8
10.1 16.2 26.6 24.7
A B
DC
Fig. 4. CD spectra and UV spectra assay of CNA and its mutants. (A)
CD spectra of WT CNA and its three mutants. (B) CD spectra of WT
CNA and its three mutants in the presence of CNB. (C) UV spectra of
WT CNA and its mutant derivatives. (D) UV spectra of WT CNA and
its three mutants in the presence of CNB.
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between CNA and CNB, we mutated the Glu53 of CNA to
Glycine (E53G) and Alanine (E53A), and the Lys134 of CNB
to Glycine (K134G).
The mutations at Lys134 of CNB and Glu53 of CNA both
block formation of the salt bridge, but their eﬀects on the in-
teraction of CNA and CNB were diﬀerent. The eﬀect of
K134G on the phosphatase activity of WT CNA was weaker
than that of CNB and the mutation at Glu53 of CNA greatly
decreased its sensitivity to CNB. The presence of CNB in-
creased the phosphatase activity of WT CNA about 24-fold,
whereas with E53G and E53A it increased at most 3-fold. The
diﬀerences between the CD spectra, as well as the computed
secondary structures contents, and the UV-absorbance spectra
indicate that our mutation aﬀects the correct binding and the
correct conformation forming between CNA and CNB. It is
reported that a synthesized BBH peptide can bind to CNB in
vitro [24]. Though much lower, CNB do can activate the
phosphatase activity of E53G and E53A with RII as the sub-
strate. In the preliminary experiment, CNB can activate E53G
and E53A to a relative higher degree (data not shown). And
so, our mutation at the salt bridge unlikely disrupts the in-
teraction between CNA and CNB. Thus, the phosphatase ac-
tivity assays and the structural assays both indicate that
mutation of the salt bridge aﬀects the closeness of the associ-
ation between CNA and CNB and reduces the activation of
CNA phosphatase activity by CNB.
A novel CN splice variant that contains the N-terminus, the
CaM binding domain and the autoinhibitory domain of CNAhas been cloned from human spinal cord cells. This splice
variant revealed a stimulating eﬀect on CN activity at low
Ca2þ concentrations as well as protein-protein interaction
with the catalytic CN holoenzyme [25]. This result brings a
possibility that the N-terminus of CNA can regulate the
phosphatase activity of CN, maybe. In our experiment, E53G
and E53A both had somewhat higher phosphatase activity
than WT CNA probably because glycine is more ﬂexible than
other amino acids. In the crystal structure, CNA residues 1–
13 are invisible due to their high mobility. Mutation of glu-
tamic acid to glycine may increase this ﬂexibility greatly for
the 54th residue of CNA is also glycine. This excess ﬂexibility
possibly aﬀects the correct orientation of the N-terminus and
even cause unwanted interaction with other domains of CNA.
This maybe the reason that E53G shows obviously higher
phosphatase activity than WT CNA and when glutamic acid
is substituted by alanine, an amino acid not so ﬂexible as
glycine, its phosphatase activity is only 1.1 times that of WT
CNA.
This speculation can also explain why K134G retained 75%
of the normal ability to activate CNA, but that mutation at
Glu53 made CNA almost completely insensitive to CNB. Our
mutation at Glu53 of CNA may cause incorrect orientation of
the N-terminus of CNA, apart from disrupting the salt bridge.
This may aﬀect the interaction between the N-terminus and the
C-terminus of CNB, and thus the eﬀect of CNB binding to
CNA can not be transferred to CNA eﬀectively. Furthermore,
Glu53 of CNA is an important amino acid for CN to form
correct conformation.
In conclusion, the phosphatase activity and structural assays
both indicate that mutation of the salt bridge aﬀects the
closeness of the association between CNA and CNB and
greatly reduces the activation of CNA phosphatase activity by
CNB. We speculate that the salt bridge plays its role in
transferring the eﬀect of CNB binding to CNA through two
ways: stabilize the interaction between two subunits and ensure
the correct orientation of the N-terminus of CNA. That is
maybe the reason that mutation at CNB and CNA to defect
the salt bridge will cause distinctly diﬀerent eﬀect in CN
function.
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